Recon: FDA approves Janssen’s prostate cancer combo; Pfizer wins FDA accelerated approval for multiple myeloma drug
ReconJason Scott
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsProduct Lifecycle